What service do you need? Contact Request

NCT07596173

A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

← Hub

Registry fields

Overall status: COMPLETED
Conditions: Diphtheria-Tetanus-acellular Pertussis Vaccines
Study type: INTERVENTIONAL
Phase: PHASE3
Primary purpose: PREVENTION
Intervention type: BIOLOGICAL
Interventions: dTpa vaccine
Lead sponsor: GlaxoSmithKline (INDUSTRY)

Cached at: 2026-09-10 09:07:53

View on ClinicalTrials.gov

Brief summary

The purpose of the study is to assess the immune response, reactogenicity and safety of a booster dose of dTpa vaccine 1 month after vaccination in healthy Japanese participants aged 11 to \<13 years.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report